项目名称:廊坊市万康药业有限公司建设 1500公斤/年洛伐他汀项目

　　项目内容:拟利用外资建设1500Kg/年洛伐他汀项目,项目预计总投资750万美元,拟利用外资500万美元,其中:中方以土地、厂房、设备、水、电等基础设施和技术投入,希望外方以现汇和相关设备投入。

　　市场分析:洛伐他汀是一种新型降血脂药物,具有抑制体内生物合成胆固醇的高度选择性和极低的毒副作用,是治疗心血管疾病的首选药品。目前洛伐他汀在世界畅销药中排名第四位。随着老龄人口的迅速增长,心血管疾病患者大量增加,在我国心血管疾病已占死亡原因的第一位。据测算到2005年,我国老龄人口将超过1.6亿,从而越来越多的需要安全性高且有效的降胆固醇药物进行治疗和预防。目前这类药物我国主要靠进口,国内、外市场非常广阔。

　　经济效益分析:该项目年产1500公斤洛伐他汀药品,投产后年销售收入1050万美元,实现利润590万美元,投资利税106%,内部收益率91%,投资回收期2年。

　　中方企业现状:廊坊市万康药业有限公司系股份合作制企业,始建于1994年,占地面积3.4万平方米,建筑面积7800平方米,其中制药车间1500平方米,具备年产2.5亿粒药片和1亿粒胶囊的生产能力,拥有洛伐他汀生产技术和批准文件。此外还有一条年产2.5万吨高品质天然矿泉水生产线。公司固定资产净值290万美元，水、电、气、通讯等基础设施完备,且有扩大生产空地,现有职工80人,高级技术人员5人,中级技术人员9人。

　　投资环境:该公司地处京、津、保三角地中心、地理位置优越,交通便捷。距京、津两市各70公里,距京九铁路霸州站15公里,距京津塘高速公里30公里。程控电话可通国内、国际。企业所在地周围三公里内没有工厂，一公里内没有村庄，环境净化级别符合GMP标准。

　　合作方式:合资、合作

客户服务：(010)82628888-6786　　点击此处在线咨询或留言

　　免责声明：该栏目所展示的项目信息其真实性、准确性和合法性由信息发布人负责。新浪网不提供任何保证，并不承担任何法律责任。详细内容请见《法律声明》

　　Project Name: A project to produce lofting by Langfang Wankang Pharmaceutical Co. Ltd.

　　Project Content: Utilizing the foreign capital to produce lofting. The designed annual production capacity is 1500 Kilogram. The estimated total investment will be US $ 7.5 million in which US $ 5 million foreign capital is expected. The Chinese part will invest by the means of land, workhouse, basic facilities and technology. Hope the foreign part to invest in foreign exchange and the related equipment.

　　Market Analysis: Lofting is a kind of new type blood—fat lowering medicine. Because of the high selection for restraining the biosynthesis cholesterol and the lower toxicity, it has been the first choice medicine for treating the heart and blood vessel disease. But in our country, the medicine is mainly dependent on importing. So, the project has a broad market.

　　Economic Benefit Analysis: When the project come into operation, the annual selling income will be US $ 10.5 million and profit US $ 5.9 million. The investment profit rate will be 106 per cent and its internal earning ratio 91 per cent. The investment recoverable period is 2 years.

　　Existing conditions of Chinese Enterprise: Langfang Wankang Pharmaceutical Co. Ltd. was set up in 1994. It covers an area of 3400 sq. m. and the building area is 7800 sq. m. The company has the production capacity for 2.5 million pieces tablet and 100 million pieces capsule. One 25000 tons mineral water production line has also been put into operation. The company has possessed the production technology and the instrument of ratification for producing lofting. The company takes the fixed net assets US $ 2.9 million and enjoys the perfect basic facilities.

　　Investment Environment: Taking the advantages of preferential location and convenient transportation, the company is neighboring Beijing and Tianjin and closing to Jingjiu Railway and Beijing—Tianjin—Tanggu Expressway. In the company’s surrounding area, no polluting factories exist.

　　Cooperation Form: Jointly operated or Cooperative management.